Volume | 1,652,069 |
|
|||||
News | (2) | ||||||
Day High | 1.34 | Low High |
|||||
Day Low | 1.20 |
Company Name | Stock Ticker Symbol | Market | Type |
---|---|---|---|
Veru Inc | VERU | NASDAQ | Common Stock |
Open Price | Low Price | High Price | Close Price | Prev Close |
---|---|---|---|---|
1.34 | 1.20 | 1.34 | 1.23 | 1.27 |
Trades | Volume | VWAP | Dollar Volume | Avg Volume | 52 Week Range |
---|---|---|---|---|---|
7,634 | 1,652,069 | $ 1.24 | $ 2,041,863 | - | 0.36 - 1.92 |
Last Trade Time | Type | Quantity | Stock Price | Currency |
---|---|---|---|---|
19:59:27 | formt | 130 | $ 1.36 | USD |
Veru Inc Financials
Market Cap | Shares in Issue | Float | Revenue | Profit/Loss | EPS | PE Ratio |
---|---|---|---|---|---|---|
178.59M | 146.38M | - | 16.3M | -93.09M | -0.64 | - |
Short Interest | Dividends Per Share | Dividend Yield | Ex-Div Date | Insider B/S | Insider % Owned |
---|---|---|---|---|---|
- | - | - | - |
Veru News
Loading Messages....
{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}} |
Loading Messages....
Historical VERU Price Data
Period | Open | High | Low | VWAP | Avg. Daily Vol | Change | % |
---|---|---|---|---|---|---|---|
1 Week | 1.39 | 1.50 | 1.20 | 1.34 | 1,383,238 | -0.03 | -2.16% |
1 Month | 1.24 | 1.75 | 1.17 | 1.45 | 2,077,607 | 0.12 | 9.68% |
3 Months | 0.601 | 1.92 | 0.54 | 1.26 | 2,409,551 | 0.759 | 126.29% |
6 Months | 0.96 | 1.92 | 0.36 | 0.9411557 | 2,168,920 | 0.40 | 41.67% |
1 Year | 1.07 | 1.92 | 0.36 | 0.9764389 | 1,621,238 | 0.29 | 27.10% |
3 Years | 8.20 | 24.55 | 0.36 | 10.31 | 4,383,543 | -6.84 | -83.41% |
5 Years | 1.72 | 24.56 | 0.36 | 10.15 | 3,271,738 | -0.36 | -20.93% |
Veru Description
Veru Inc is a biopharmaceutical company focused on urology and oncology. It develops prescription products for benign prostatic hyperplasia hot flashes associated with cancer treatment, male infertility, and novel chemotherapies for a variety of cancers. The company currently operates in two reporting segments: Sexual health business and Research & development. Some of its products include Zuclomiphene, Veru-111, Veru-100, FC2, and Roman Swipes. The company generates the majority of its revenue from the United States. |